Comparison · NCT03409367-3f7bb662
Daily Emollient vs Natural Skin: Provider-diagnosed Asthma
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Daily Emollient vs Natural Skin: Provider-diagnosed Asthma. Trial comparisons, record NCT03409367-3f7bb662. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03409367-3f7bb662
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0278 | 0.0167 | 0.0462 | wilson | |
| Risk in group 2 | 0.0263 | 0.0154 | 0.0445 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00152 | -0.0198 | 0.0228 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.06 | 0.502 | 2.23 | log | |
| Odds ratio, group 1 over group 2 | 1.06 | 0.493 | 2.28 | log | |
| Number needed to treat, for one more participant with the outcome on Daily Emollient than on Natural Skin | 659 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Daily Emollient | Parents assigned to the intervention arm receive a lipid-rich emollient and educational materials promoting once daily full-body emollient use until infant age 24 months. Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream: Lipid-rich emollient serving as skin barrier | 14 | 503 | OG000 |
| Group 2 | Natural Skin | Parents assigned to the control arm receive educational materials promoting general infant skin care guidelines only and asked to refrain from emollient use unless dry skin develops (current standard of care guidelines). | 13 | 494 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Provider-diagnosed Asthma
- Description
- Health records at primary care practice include at least one diagnosis of asthma.
- Time frame
- up to 24 months
- Population
All participants with (a) at least one primary care visit between 20 and 27 months of age or (b) asthma diagnosis earlier than 20 months. Numbers represent participants according to arm randomized, regardless of adherence to study instructions.
Source ClinicalTrials.gov
Trial
- Title
- A Community-based Assessment of Skin Care, Allergies, and Eczema
- NCT number
- NCT03409367
- Phases
- NA
- Conditions
- Atopic Dermatitis, Atopic Disorders, Eczema, Atopic Eczema
- Interventions
- Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream
- Lead sponsor
- Oregon Health and Science University
- Results first posted
- 2025-08-15
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03409367?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03409367-3f7bb662